T1	Participants 0 45	EEG mapping and psychopharmacological studies
T2	Participants 51 80	denbufylline in SDAT and MID.
T3	Participants 82 106	Computed tomography (CT)
T4	Participants 108 135	electroencephalograms (EEG)
T5	Participants 185 274	96 mildly to moderately demented patients (72 women, 24 men), aged 61-96 years (mean 82),
T6	Participants 330 360	off drugs for at least 2 weeks
T7	Participants 404 495	Marshall-Hachinski ischemic score and CT in 45 senile dementia of the Alzheimer type (SDAT)
T8	Participants 500 539	51 multiinfarct dementia (MID) patients
T9	Participants 683 726	Sandoz Clinical Assessment Geriatric (SCAG)
T10	Participants 746 778	Clinical Global Impression (CGI)
T11	Participants 784 821	Digit Symbol Substitution Test (DSST)
T12	Participants 827 879	Trail-Making Test (TMT) and the Digit Span Test (DS)
T13	Participants 1575 1762	both the degenerative and vascular type of dementia exhibited a therapeutic benefit that could be objectified at the neurophysiological level by EEG mapping in an improvement of vigilance
